| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/12/2007 | CN101032489A Cefprozil dispersible table and the preparing method |
| 09/12/2007 | CN101032487A Levofloxacin mesylate transfusion and the preparing method |
| 09/12/2007 | CN101032486A Medical plants intensifier having antifungal activity and drug tolerance of reversion azole antifungal agents |
| 09/12/2007 | CN101032482A Compound preparation resisting coxsackie virus and herpesvirus |
| 09/12/2007 | CN101032471A Chuanhuning lipid freeze-dry powder agent and preparing method thereof |
| 09/12/2007 | CN101032456A Hairdressing combination made of natural vegetable and preparing method thereof |
| 09/12/2007 | CN100336902C Isolated phages and their use in food or pet food products |
| 09/12/2007 | CN100336823C Specific chicken CpG ODN and its application |
| 09/12/2007 | CN100336809C Peptide deformylase inhibitors |
| 09/12/2007 | CN100336535C Children health pectoral mixture for treating child wind and heat caused by exopathogen and its preparing method |
| 09/12/2007 | CN100336523C Rhubarb lyophilized injection and preparation method thereof |
| 09/12/2007 | CN100336521C Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 09/12/2007 | CN100336511C Release-controlled oral Roxithromycin formulation |
| 09/12/2007 | CN100336510C 头孢匹胺组合物 Cefpiramide composition |
| 09/12/2007 | CN100336503C Liganning tablet and preparing method |
| 09/11/2007 | USRE39836 Macrolide antinfective agents |
| 09/11/2007 | US7268227 Posh nucleic acids, polypeptides and related methods |
| 09/11/2007 | US7268219 May be used to promote lysis of the target cell by T cells in the immune system or to promote proliferation of specific T cell clones |
| 09/11/2007 | US7268209 Peptides, derivates thereof, process for producing the same, novel strain producing the same, and antiviral agent comprising the same as active ingredient |
| 09/11/2007 | US7268155 Photosensitizer conjugates for pathogen targeting |
| 09/11/2007 | US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents |
| 09/11/2007 | US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression |
| 09/11/2007 | US7268128 Increase the intracellular cAMP level and further inhibit the activation of T cells; allergic diseases, inflammatory or immunological diseases |
| 09/11/2007 | US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 09/11/2007 | US7268122 Viricides; aids therapy |
| 09/11/2007 | US7268119 Tricyclic nucleosides or nucleotides as therapeutic agents |
| 09/11/2007 | US7268112 Prophylaxis of bone disorders comprising administering insulin and derivatives, and optionally in combination with peptide growth factors, metabolic antagonist, osteoprotegerins, synovial or antiinflammatory agents, in sustained release form |
| 09/11/2007 | US7267963 Modified plant viruses and methods of use thereof |
| 09/11/2007 | US7267824 Veterinary medicine; induce immunology response |
| 09/11/2007 | US7267813 Inhalation particles incorporating a combination of two or more active ingredients |
| 09/11/2007 | CA2402640C Antiseptic compress |
| 09/11/2007 | CA2388802C Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
| 09/11/2007 | CA2372720C Androgen glycosides and androgenic activity thereof |
| 09/11/2007 | CA2349487C Bupropion to treat viral diseases |
| 09/11/2007 | CA2310536C Erythropoietin derivatives |
| 09/11/2007 | CA2193967C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 09/11/2007 | CA2163175C Anti-viral aromatic o-alkylated oximes, ethers and thioethers |
| 09/07/2007 | WO2007100643A2 Methods of using antibodies against human il-22 |
| 09/07/2007 | WO2007100098A1 Multimer of extracellular domain of cell surface functional molecule |
| 09/07/2007 | WO2007099999A1 Novel glycolipid and use thereof |
| 09/07/2007 | WO2007099993A1 Antiviral peptide and antiviral agent |
| 09/07/2007 | WO2007099981A1 Galactose derivative, drug carrier and medicinal composition |
| 09/07/2007 | WO2007099915A1 Antiviral agent |
| 09/07/2007 | WO2007099869A1 Therapeutic and preventive agent for hcv |
| 09/07/2007 | WO2007099345A1 Medical use of bmp-2 and/ or bmp-4 |
| 09/07/2007 | WO2007099302A2 Methods of maintaining oral health in animals using morpholine derivatives |
| 09/07/2007 | WO2007099166A1 Pyrazolo-pyridine derivatives active as kinase inhibitors |
| 09/07/2007 | WO2007098588A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 09/07/2007 | WO2007075915A3 Monoclonal antibodies against orthopoxviruses |
| 09/07/2007 | WO2007075914A3 Monoclonal antibodies against orthopoxviruses |
| 09/07/2007 | WO2007072032A3 Neisseria meningitidis vaccines and their use |
| 09/07/2007 | WO2007071997A3 Method of eliciting immune response |
| 09/07/2007 | WO2007062832A3 Vaccines containing non-live antigenic vectors |
| 09/07/2007 | WO2007056153A3 Peptide-dicer substrate rna conjugates as delivery vehicles for sirna |
| 09/07/2007 | CA2643100A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 09/07/2007 | CA2642570A1 Methods of using antibodies against human il-22 |
| 09/07/2007 | CA2638832A1 Chimeric vaccine antigens against the avian influenza virus |
| 09/07/2007 | CA2638797A1 Galactose derivative, drug carrier and medicinal composition |
| 09/07/2007 | CA2638757A1 Chimeric adenoviral vectors |
| 09/07/2007 | CA2611577A1 Antibiotic kit and composition and uses thereof |
| 09/06/2007 | US20070208167 Compounds and methods for modulating activation of NF-kappaB |
| 09/06/2007 | US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators |
| 09/06/2007 | US20070208033 Amine compound and use thereof |
| 09/06/2007 | US20070208008 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 09/06/2007 | US20070208007 Amine-Based Compound and Use Thereof |
| 09/06/2007 | US20070207163 Recombinant soluble Fc receptors |
| 09/06/2007 | US20070207160 Apoptosis inhibitors |
| 09/06/2007 | US20070207153 Therapeutic Agents For Inner Ear Disorders Containing An Il-6 Antagonist As An Active Ingredient |
| 09/06/2007 | US20070207146 Therapeutic using a bispecific antibody |
| 09/06/2007 | US20070207090 Mucosal meningococcal vaccines |
| 09/06/2007 | DE202007006018U1 Lippen-/Nasensalbe gegen Herpes Cleft lip / nose ointment for herpes |
| 09/06/2007 | DE102006009928A1 Substituierte Arylsulfonamide Substituted aryl sulfonamides |
| 09/06/2007 | DE102006008880A1 Aminopyrimidinderivate Aminopyrimidine derivatives |
| 09/05/2007 | EP1829962A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 09/05/2007 | EP1829961A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 09/05/2007 | EP1829892A2 Staphylococcus aureus proteins and nucleic acids |
| 09/05/2007 | EP1829888A1 Anti-inflammatory compounds and uses thereof |
| 09/05/2007 | EP1829887A1 Cpg single-strand deoxynucleotides for use as adjuvant |
| 09/05/2007 | EP1829885A1 Modified 5'- phosphonate azidothymidine-potential anti-viral preparations |
| 09/05/2007 | EP1829881A1 Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same |
| 09/05/2007 | EP1829551A1 Modified heat shock protein-antigenic peptide complex |
| 09/05/2007 | EP1829530A2 Stabilisation of active agents by formulation into nanoparticulate form |
| 09/05/2007 | EP1829529A1 Controlled release compositions of estradiol metabolites |
| 09/05/2007 | EP1828247A2 Binding molecules capable of neutralizing west nile virus and uses thereof |
| 09/05/2007 | EP1828223A2 Novel betulin derivatives, preparation thereof and use thereof |
| 09/05/2007 | EP1828167A2 Acrylamide derivatives as antibiotic agents |
| 09/05/2007 | EP1827482A1 Novel uses of egf |
| 09/05/2007 | EP1827457A1 Uridine derivatives as antiviral drugs against a flaviviridae, especially hcv |
| 09/05/2007 | EP1827449A2 The use of novel antibacterial compounds |
| 09/05/2007 | EP1827446A2 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses |
| 09/05/2007 | EP1827433A1 A composition comprising at least 3 different diols |
| 09/05/2007 | EP1730116B1 4-carbox pyrazole derivates useful as anti-viral agents |
| 09/05/2007 | EP1689698A4 Bis-cationic compounds and use thereof |
| 09/05/2007 | EP1487811B1 N-sulfonylurea apoptosis promoters |
| 09/05/2007 | EP1458391B1 A method of treating bacterial infections using gemifloxacin or a salt thereof and a beta-lactam antibiotic |
| 09/05/2007 | EP1357920B1 Compositions and method of tissue superoxygenation |
| 09/05/2007 | EP1336611B1 Dehalogeno compounds |
| 09/05/2007 | EP1259541B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/05/2007 | EP1113806B1 Anionic or cationic dendrimer antimicrobial or antiparasitic compositions |
| 09/05/2007 | EP1093465B1 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |